Skip to content
TrustList
Brightstone Venture Capital logo
Venture capital firm

Brightstone Venture Capital

Early-growth venture fund investing in data storage and drug discovery tools, run by experienced operators

  • Cybersecurity
  • Management
  • Banking
Brightstone Venture Capital cover

About Brightstone Venture Capital

Brightstone Venture Capital manages a venture fund for companies in the early growth stage. It says it works with extraordinary entrepreneurs to build exceptional companies, and it relies on the operating experience and investment background of its partners. The firm says its partners bring about fifteen years of venture fund partnership, ten years in technology investment banking, decades of corporate board service and about a quarter century of portfolio management in technology and life sciences businesses.

Technology and life sciences focus

The fund invests mainly in two sectors: data storage and management, and drug discovery tools and platforms. The partners have sat on the boards of companies in areas including healthcare, real estate technology, medical devices and consumer services. Their experience covers oil and gas, information technology, life sciences and consumer products, and the firm also points to founder and management experience in financial technology, cybersecurity and artificial intelligence applied to life sciences.

Companies the firm lists from its history

The firm lists a range of companies its partners have backed or helped build. VRChat operates a platform for creating social virtual reality experiences. StemoniX provides stem cell based micro-organ models that pharmaceutical and research organizations use to test drug toxicity and efficacy. BiteSquad runs an on-demand food delivery platform and was sold to Waitr. Gravie offers a health insurance platform that lets consumers choose, buy and pay for coverage in one place. Miromatrix works on biological replacement organs, and HomeSpotter made a mobile real estate search application. FlipGrid, a video platform for classrooms, was sold to Microsoft, and CodeStream, which lets developers annotate code and chat within their editor, was sold to New Relic.

Early-stage companies still in the portfolio

Other entries include Vathys, which builds deep learning processors, and Viosera, which works to predict and block the evolution of drug resistance. Intact Therapeutics is developing a localized drug delivery platform, and Aria CV a pulmonary assist device for people with pulmonary arterial hypertension. Cryosa is developing treatments for sleep disordered breathing, Afriex runs a blockchain based mobile remittance platform, and Xplore provides a mission platform for destinations beyond low Earth orbit. The firm also highlights a storage product that it says is faster than cloud object storage yet cheaper than archive tiers.

TrustList summary

Brightstone Venture Capital manages a venture fund aimed at early-growth stage companies. Its partners bring operating and investing backgrounds, and the firm describes its purpose as helping entrepreneurs build strong companies.

The partners' experience covers venture investing, technology investment banking, portfolio management and senior management roles. Several have held board seats at technology and life science businesses.

Services

  • Early-growth investment: funding for companies that are past the very first stage.
  • Data storage and management: a stated technology focus.
  • Drug discovery tools and platforms: a stated life sciences focus.
  • Board-level guidance: partners with director experience at companies such as Homespotter, Celcuity and Agiliti.

Who it works with

Entrepreneurs building technology and life science companies. Its portfolio has included AI-based revenue optimisation, a virtual reality social network and BiteSquad, a food delivery business that was sold to Waitr.

Key facts

  • Stage: early growth
  • Sectors: technology and life sciences
  • Partner background: venture investing, investment banking and executive roles

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Cybersecurity
  • Management
  • Banking

Ask TrustList to introduce you to Brightstone Venture Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Brightstone Venture Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Brightstone Venture Capital.

Brightstone Venture Capital alternatives

Similar listings buyers compare against this one.

Italian venture capital manager investing in technology start-ups from late seed to Series B or C

Venture capital firm investing in early to growth-stage fintech companies through a network of banks

Venture capital firm investing in information technology and digital health companies in Europe and Brazil

Pre-seed and seed investor in software and Web3 startups, active since 2019

A fund management services provider supporting fund managers, family offices and investors worldwide